- Home
- OCGN vs SMTI Comparison
OCGN vs SMTI Comparison
Compare OCGN & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCGN
- SMTI
- Stock Information
- Founded
- OCGN 2013
- SMTI 1982
- Country
- OCGN United States
- SMTI United States
- Employees
- OCGN N/A
- SMTI N/A
- Industry
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- SMTI Medical/Dental Instruments
- Sector
- OCGN Health Care
- SMTI Health Care
- Exchange
- OCGN Nasdaq
- SMTI Nasdaq
- Market Cap
- OCGN 278.3M
- SMTI 273.6M
- IPO Year
- OCGN N/A
- SMTI N/A
- Fundamental
- Price
- OCGN $0.93
- SMTI $28.00
- Analyst Decision
- OCGN Strong Buy
- SMTI Strong Buy
- Analyst Count
- OCGN 3
- SMTI 2
- Target Price
- OCGN $6.00
- SMTI $49.50
- AVG Volume (30 Days)
- OCGN 8.5M
- SMTI 38.0K
- Earning Date
- OCGN 08-07-2025
- SMTI 08-11-2025
- Dividend Yield
- OCGN N/A
- SMTI N/A
- EPS Growth
- OCGN N/A
- SMTI N/A
- EPS
- OCGN N/A
- SMTI N/A
- Revenue
- OCGN $4,522,000.00
- SMTI $91,569,883.00
- Revenue This Year
- OCGN N/A
- SMTI $23.53
- Revenue Next Year
- OCGN N/A
- SMTI $5.93
- P/E Ratio
- OCGN N/A
- SMTI N/A
- Revenue Growth
- OCGN N/A
- SMTI 34.65
- 52 Week Low
- OCGN $0.52
- SMTI $25.86
- 52 Week High
- OCGN $1.98
- SMTI $39.08
- Technical
- Relative Strength Index (RSI)
- OCGN 44.71
- SMTI 41.41
- Support Level
- OCGN $0.95
- SMTI $27.80
- Resistance Level
- OCGN $1.09
- SMTI $29.02
- Average True Range (ATR)
- OCGN 0.10
- SMTI 1.09
- MACD
- OCGN -0.03
- SMTI 0.08
- Stochastic Oscillator
- OCGN 5.03
- SMTI 32.96
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.